What does CUSIP 33830X104 represent in this 13F holders report?

CUSIP 33830X104 is the security identifier for FPRX - FIVE PRIME THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held FPRX - FIVE PRIME THERAPEUTICS INC - COM in Q1 2018?

126 institutional investors reported FPRX - FIVE PRIME THERAPEUTICS INC - COM for Q1 2018. Use the holders table for investor-level position and value details.

FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / COM
Total 13F shares: 32,332,350
Share change: +6,123,294
Total reported value: $555,217,759
Put/Call ratio: 512%
Price per share: $17.18
Number of holders: 126
Value change: +$96,760,885
Number of buys: 85
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 33830X104:

Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q1 2018

As of 31 Mar 2018, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,332,350 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, EcoR1 Capital, LLC, PRICE T ROWE ASSOCIATES INC /MD/, VICTORY CAPITAL MANAGEMENT INC, DIMENSIONAL FUND ADVISORS LP, and BB BIOTECH AG. This page lists 126 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.